Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Combining amino acid and stem cell therapy may help manage hepatocutaneous syndrome in dogs.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

UV light helped human hair transplants survive in mice without broad immunosuppression.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

Combination therapies might work better for some vitiligo patients, but results vary.

COVID-19 infection may trigger alopecia areata in some patients.

Topical vitamin D is effective in treating vitiligo with few side effects.

Sodium valproate caused vomiting, hair loss, loss of appetite, abdominal pain, weight gain, and anemia in young children with epilepsy.

Niosomes are the most effective at delivering drugs to the skin with minimal absorption into the body.

Wharton’s Jelly stem cells from the umbilical cord improve skin healing and hair growth without scarring.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Alopecia Areata might be linked to Crohn's disease.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Antioxidants might help with Long Covid by addressing oxidative stress and nutrient imbalances.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.